272 related articles for article (PubMed ID: 19047484)
1. Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane.
Orcel H; Albizu L; Perkovska S; Durroux T; Mendre C; Ansanay H; Mouillac B; Rabié A
Mol Pharmacol; 2009 Mar; 75(3):637-47. PubMed ID: 19047484
[TBL] [Abstract][Full Text] [Related]
2. Gq-mediated activation of c-Jun N-terminal kinase by the gastrin-releasing peptide-preferring bombesin receptor is inhibited upon costimulation of the Gs-coupled dopamine D1 receptor in COS-7 cells.
Chan AS; Wong YH
Mol Pharmacol; 2005 Nov; 68(5):1354-64. PubMed ID: 16061771
[TBL] [Abstract][Full Text] [Related]
3. Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins.
Michal P; El-Fakahany EE; Dolezal V
J Pharmacol Exp Ther; 2007 Feb; 320(2):607-14. PubMed ID: 17065363
[TBL] [Abstract][Full Text] [Related]
4. Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.
Cheng LL; Stoev S; Manning M; Derick S; Pena A; Mimoun MB; Guillon G
J Med Chem; 2004 Apr; 47(9):2375-88. PubMed ID: 15084136
[TBL] [Abstract][Full Text] [Related]
5. Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
Bodenstein J; Venter DP; Brink CB
J Pharmacol Exp Ther; 2005 Aug; 314(2):891-905. PubMed ID: 15857948
[TBL] [Abstract][Full Text] [Related]
6. An investigation of whether agonist-selective receptor conformations occur with respect to M2 and M4 muscarinic acetylcholine receptor signalling via Gi/o and Gs proteins.
Mistry R; Dowling MR; Challiss RA
Br J Pharmacol; 2005 Feb; 144(4):566-75. PubMed ID: 15655507
[TBL] [Abstract][Full Text] [Related]
7. Small-molecule vasopressin-2 receptor antagonist identified by a g-protein coupled receptor "pathway" screen.
Yangthara B; Mills A; Chatsudthipong V; Tradtrantip L; Verkman AS
Mol Pharmacol; 2007 Jul; 72(1):86-94. PubMed ID: 17435162
[TBL] [Abstract][Full Text] [Related]
8. Localization of the kappa opioid receptor in lipid rafts.
Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of G(q/11alpha) protein shapes mGlu1 and mGlu5 receptor-mediated single cell inositol 1,4,5-trisphosphate and Ca(2+) signaling.
Atkinson PJ; Young KW; Ennion SJ; Kew JN; Nahorski SR; Challiss RA
Mol Pharmacol; 2006 Jan; 69(1):174-84. PubMed ID: 16234485
[TBL] [Abstract][Full Text] [Related]
11. Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding.
Albizu L; Balestre MN; Breton C; Pin JP; Manning M; Mouillac B; Barberis C; Durroux T
Mol Pharmacol; 2006 Nov; 70(5):1783-91. PubMed ID: 16926282
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between G(s)- and G(q)-coupled pathways in regulation of interleukin-4 by A(2B) adenosine receptors in human mast cells.
Ryzhov S; Goldstein AE; Biaggioni I; Feoktistov I
Mol Pharmacol; 2006 Aug; 70(2):727-35. PubMed ID: 16707627
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus.
Skrzydelski D; Lhiaubet AM; Lebeau A; Forgez P; Yamada M; Hermans E; Rostene W; Pelaprat D
Mol Pharmacol; 2003 Aug; 64(2):421-9. PubMed ID: 12869647
[TBL] [Abstract][Full Text] [Related]
14. The rapid activation of N-Ras by alpha-thrombin in fibroblasts is mediated by the specific G-protein Galphai2-Gbeta1-Ggamma5 and occurs in lipid rafts.
Lents NH; Irintcheva V; Goel R; Wheeler LW; Baldassare JJ
Cell Signal; 2009 Jun; 21(6):1007-14. PubMed ID: 19250965
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic receptor stimulation promotes G alpha s internalization through lipid rafts: a study in living cells.
Allen JA; Yu JZ; Donati RJ; Rasenick MM
Mol Pharmacol; 2005 May; 67(5):1493-504. PubMed ID: 15703379
[TBL] [Abstract][Full Text] [Related]
16. Relaxin family peptide receptor (RXFP1) coupling to G(alpha)i3 involves the C-terminal Arg752 and localization within membrane Raft Microdomains.
Halls ML; van der Westhuizen ET; Wade JD; Evans BA; Bathgate RA; Summers RJ
Mol Pharmacol; 2009 Feb; 75(2):415-28. PubMed ID: 19029286
[TBL] [Abstract][Full Text] [Related]
17. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
Reymond-Marron I; Tribollet E; Raggenbass M
Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
[TBL] [Abstract][Full Text] [Related]
18. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
[TBL] [Abstract][Full Text] [Related]
19. Engineering a V(2) vasopressin receptor agonist- and regulator of G-protein-signaling-sensitive G protein.
Feng GJ; Cavalli A; Milligan G
Anal Biochem; 2002 Jan; 300(2):212-20. PubMed ID: 11779113
[TBL] [Abstract][Full Text] [Related]
20. Mastoparan inhibits beta-adrenoceptor-G(s) signaling by changing the localization of Galpha(s) in lipid rafts.
Sugama J; Yu JZ; Rasenick MM; Nakahata N
Cell Signal; 2007 Nov; 19(11):2247-54. PubMed ID: 17692506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
